Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype

Cancer Res. 2013 Jan 15;73(2):990-9. doi: 10.1158/0008-5472.CAN-12-2895. Epub 2012 Nov 29.

Abstract

Phenotypic similarities have long been recognized between subpopulations of glioma and neural stem cells. Many of these similar properties, including the robust abilities to self-renew, migrate, and invade, are hallmarks of glioma cells that render them extremely aggressive. However, the molecular mechanisms underlying this character, particularly in glioma stem-like cells that drive this disease, remain poorly understood. Here, we report the results of a differential miRNA expression screen that compared glioma and neural stem cells, where we found that miR-204 was markedly downregulated in both types of cells. Mechanistic investigations revealed that miR-204 simultaneously suppressed self-renewal, stem cell-associated phenotype, and migration of glioma cells by targeting the stemness-governing transcriptional factor SOX4 and the migration-promoting receptor EphB2. Restoring miR-204 expression in glioma cells suppressed tumorigenesis and invasiveness in vivo and increased overall host survival. Further evaluation revealed that the miR-204 promoter was hypermethylated and that attenuating promoter methylation was sufficient to upregulate miR-204 in glioma cells. Together, our findings reveal miR-204 as a pivotal regulator of the development of stem cell-like phenotypes and cell motility in malignant glioma cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Neoplasms / genetics*
  • Cell Line
  • Cell Line, Tumor
  • Cell Movement / genetics
  • DNA Methylation
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic*
  • Glioma / genetics*
  • Humans
  • Mice
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • MicroRNAs / pharmacology
  • Neoplastic Stem Cells / pathology*
  • Neural Stem Cells / pathology
  • Phenotype
  • Transplantation, Heterologous

Substances

  • MIRN204 microRNA, human
  • MicroRNAs